# Dexlansoprazole delayed release

NDC: 71335-3071
Generic name: dexlansoprazole
Labeler / Manufacturer: Bryant Ranch Prepack
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20221201

FDA application: ANDA202666

## Active ingredients

- DEXLANSOPRAZOLE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71335-3071"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71335-3071
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d3d485-5f87-4405-b940-490fa4ccf9cc